Index

Title of Article

Row

Sedighi B, Haghdoost A, Jangipour Afshar P, Abna Z, Bahmani S, Jafari S. Multiple sclerosis and COVID-19: A retrospective study in Iran. Plos one. 2023 Mar 23;18(3):e0283538. IF:3.7

Sedighi B, Abedini Parizi M, Haghdoost AA, Jangipour Afshar P, Shoraka HR, Jafari S. How does multiple sclerosis affect sexual satisfaction in patients' spouses?. Frontiers in Psychology. 2023 Apr 4;14:1110884. IF:3.8

Lashkari R, Loghman M, Aghaghazvini L, Saffar H, Ziaadini B, Shahriarirad R, Nekooeian M, Nejadhosseinian M, Alikhani M. Atypical Presentation of Amyloidosis in a Female Patient with Muscle Weakness. Case Reports in Medicine. 2023 Apr 13;2023. IF:0.8

Ghadiri F, Sahraian MA, Razazian N, Ashtari F, Poursadeghfard M, Nabavi SM, Navardi S, Baghbanian SM, Shaygannejad V, Harirchian MH, Beladimoghadam N. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple sclerosis and related disorders. 2023 Feb 1;70:104493. IF:2.9

Karbalaiee M, Daneshpajooh A, Khanjani N, Sohbati S, Mehrabani M, Mehrbani M, Mehrabani M. Efficacy of frankincense‐based herbal product in urinary incontinence: A randomized, double‐blind, placebo‐and active‐controlled clinical trial. Phytotherapy Research. 2023 May;37(5):1754-1770. IF:7.2

Shabestari PS, Zendehrouh S, Ahmadi A, Jafari S, Parvaresh N, Eslami M. Analyzing the network of parent‐rated ADHD symptoms before and 2 weeks after the onset of pharmaceutical treatment. Journal of Child and Adolescent Psychiatric Nursing. 2023 May 8;36(4):269-277. IF:1.5

Boostani R, Olfati N, Shamshiri H, Salimi Z, Fatehi F, Hedjazi SA, Fakharian A, Ghasemi M, Okhovat AA, Basiri K, Haghi Ashtiani B. Iranian clinical practice guideline for amyotrophic lateral sclerosis. Frontiers in Neurology. 2023 Jun 2;14:1154579. IF:3.4

Abedi N, Tashk A, Ebrahimi Meimand HA. Integration of memory specificity training and acceptance and commitment therapy techniques for older adult’s depression treatment. Journal of Psychotherapy Integration. 2023 Jun;33(2):201-212.https://doi.org/10.1037/int0000301. IF: 3.5

Eslahi M, Roshandel G, Khanjani N. Temporal Pattern and Age-Period-Cohort Analysis of Breast Cancer Incidence in Iranian Women (2009–2017). Archives of Iranian Medicine. 2023 Jun 1;26(6):285-289. IF:2.1

Iranmanesh, F., Seifadini, R., Dehesh, T., Mashayekhi, M. H. Epidemiology of Stroke 2 Years Before and During COVID-19 Pandemic in Kerman (south of Iran): a Hospital-Based Study. ARYA Atherosclerosis Journal, 2023; 19(4): 29-36. doi: 10.48305/arya.2023.41443.2880

Eslami O, Nakhaie M, Rezaei Zadeh Rukerd M, Azimi M, Shahabi E, Honarmand A, Khazaneha M. Global Trend on Machine Learning in Helicobacter within One Decade: A Scientometric Study. Global Health, Epidemiology and Genomics (GHEG). 2023 Aug 12;2023: 8856736. https://doi.org/10.1155/2023/8856736. IF:1.9

Ghadiri F, Sahraian MA, Ashtari F, Baghbanian SM, Majdi-Nasab N, Hatamian H, Faraji F, Bayati A, Sharifipour E, Jalali N, Mozhdehipanah H. Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis. Archives of Iranian Medicine. 2023 Aug 1;26(8):413-418. IF:2.1

Abbasi Kasbi N, Ghadiri F, Sahraian MA, Nahayati MA, Moghadasi AN, Langroodi HG, Poursadeghfard M, Hosseini S, Heidari H, Baghbanian SM, Kamali H. Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study. Acta Neurologica Belgica. 2023 Sep 15:1-8. IF:2.7

Ebrahimi, HA, Larizadeh M, Saba M, Jafarzadeh A. Radiotherapy Improves the Disability in Patients with Secondary Progressive Multiple Sclerosis. Journal of Biomedical Physics and Engineering, 2023; 13(4):317-322

Eslami Shahrbabaki, M., Ahmadi, A., Ahmadipour, H., Hoseini, F., Ebrahiminejad, B., Divsalar, P. The Relationship between Parents' Cognitive Characteristics and the Severity of Socio-Verbal Deficits and Stereotyped Behaviors in Children with Autism Spectrum Disorders. Journal of Isfahan Medical School, 2023; 41(732): 719-724.

Moghadasi AN, Ashtari F, Baghbanian SM, Shaygannejad V, Anjidani N, Ghadiri F, Sedighi B, Saeidi M, Amirifard H, Ayromlou H, Moghadam NB. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. 2023 Nov;26(11):647. IF:2.1

Far SS, Amiri B, Sahebozamani M, Ebrahimi HA, Zemková E. The effect of multi-function swing suspension training on upper and lower extremities function and quality of life in multiple sclerosis women with different disability status. Multiple Sclerosis and Related Disorders. 2023 Dec 1;80:105113. IF:4

Iranmanesh F. Shafiei K, Bagheri F. Frequency of Asymptomatic Intracranial and Extracranial Arterial Stenosis in a Group of Healthy General Papulation in Kerman (South of Iran). ARYA Atheroscler 2023; 19(6): 10-17. IF:0.6

Ebrahimi Meimand HA, Moghaddam MK. Evaluation of the Effects of Fasting During the Holy Month of Ramadan on Patients with Epileptic Attacks Who Visited the Emergency Room. Journal of Kerman University of Medical Sciences. 2023;30(5):267-70.